Cargando…

IL‐34 is a potential biomarker for the treatment of papillary thyroid cancer

BACKGROUND: Interleukin (IL)‐34 is a recently discovered pro‐inflammatory cytokine and is a vital regulator in different tumor types. However, the function of IL‐34 in thyroid carcinoma has yet to be investigated. In this study, we analyzed the expression of IL‐34 in human papillary thyroid cancer (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Ping, Zhang, Hao, Dong, Wenwu, Wang, Zhihong, Qin, Yuan, Wu, Changhao, Dong, Qi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439428/ https://www.ncbi.nlm.nih.gov/pubmed/32573824 http://dx.doi.org/10.1002/jcla.23335

Ejemplares similares

Potential Use of 1-25-dihydroxyvitamin D in the Diagnosis and Treatment of Papillary Thyroid Cancer
por: Zhang, Ting, et al.
Publicado: (2018)

Long non-coding RNA AGAP2-AS1 increases the invasiveness of papillary thyroid cancer
por: Shao, Liang, et al.
Publicado: (2020)

Risk factors of cervical lymph node metastasis in multifocal papillary thyroid cancer
por: Zhang, Ting, et al.
Publicado: (2022)

miRNA-299-5p regulates estrogen receptor alpha and inhibits migration and invasion of papillary thyroid cancer cell
por: Wang, Zhihong, et al.
Publicado: (2018)

Differentiation of Rat Adipose-Derived Stem Cells into Parathyroid-Like Cells
por: Zhang, Ping, et al.
Publicado: (2020)

Calcitriol enhances Doxorubicin‐induced apoptosis in papillary thyroid carcinoma cells via regulating VDR/PTPN2/p‐STAT3 pathway
por: Zhang, Ting, et al.
Publicado: (2020)

The Differences Between Multifocal and Unifocal Papillary Thyroid Carcinoma in Unilateral Lobe: A Meta-Analysis
por: Zhang, Ting, et al.
Publicado: (2021)

Estrogen Induces Metastatic Potential of Papillary Thyroid Cancer Cells through Estrogen Receptor α and β
por: Dong, Wenwu, et al.
Publicado: (2013)

RBM47/SNHG5/FOXO3 axis activates autophagy and inhibits cell proliferation in papillary thyroid carcinoma
por: Qin, Yuan, et al.
Publicado: (2022)

Comparison of Outcomes Following Thyroid Isthmusectomy, Unilateral Thyroid Lobectomy, and Total Thyroidectomy in Patients with Papillary Thyroid Microcarcinoma of the Thyroid Isthmus: A Retrospective Study at a Single Center
por: Gui, Zhiqiang, et al.
Publicado: (2020)

The NEAT1_2/miR-491 Axis Modulates Papillary Thyroid Cancer Invasion and Metastasis Through TGM2/NFκb/FN1 Signaling
por: Sun, Wei, et al.
Publicado: (2021)

Association between the expression of four upregulated miRNAs and extrathyroidal invasion in papillary thyroid carcinoma
por: Wang, Zhihong, et al.
Publicado: (2013)

MicroRNA-144 inhibits proliferation by targeting WW domain-containing transcription regulator protein 1 in papillary thyroid cancer
por: Sun, Wei, et al.
Publicado: (2018)

NEAT1_2 functions as a competing endogenous RNA to regulate ATAD2 expression by sponging microRNA-106b-5p in papillary thyroid cancer
por: Sun, Wei, et al.
Publicado: (2018)

Discovery and identification of potential biomarkers of papillary thyroid carcinoma
por: Fan, Yuxia, et al.
Publicado: (2009)

A novel necroptosis-related gene signature associated with immune landscape for predicting the prognosis of papillary thyroid cancer
por: Wang, Zhiyuan, et al.
Publicado: (2022)

Risk Factors for Central Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis
por: Sun, Wei, et al.
Publicado: (2015)

Surgery After Ultrasound-Guided Radiofrequency Ablation for Papillary Thyroid Carcinoma in 21 Patients: A Retrospective Study from a Single Center in China
por: Sun, Wei, et al.
Publicado: (2020)

Differential expression patterns of estrogen receptor (ER)-β splice variants between papillary thyroid cancer and nodular thyroid goiter
por: Dong, Wenwu, et al.
Publicado: (2012)

FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner
por: Huang, Jiapeng, et al.
Publicado: (2022)

Differential expression patterns and clinical significance of estrogen receptor-α and β in papillary thyroid carcinoma
por: Huang, Yanhong, et al.
Publicado: (2014)

Risk factors of central lymph node metastasis in cN0 papillary thyroid carcinoma: A study of 529 patients
por: Liang, Keke, et al.
Publicado: (2014)

High Incidence of Distant Metastasis Is Associated With Histopathological Subtype of Pediatric Papillary Thyroid Cancer - a Retrospective Analysis Based on SEER
por: Zeng, Xue, et al.
Publicado: (2021)

CXCL10 is a potential biomarker and associated with immune infiltration in human papillary thyroid cancer
por: Qin, Xiao-Jing, et al.
Publicado: (2021)

MFAP2 is a Potential Diagnostic and Prognostic Biomarker That Correlates with the Progression of Papillary Thyroid Cancer
por: Dong, Si Yang, et al.
Publicado: (2020)

5-Hydroxymethylcytosine as a potential epigenetic biomarker in papillary thyroid carcinoma
por: Tong, Mengying, et al.
Publicado: (2019)

Risk factors for death of follicular thyroid carcinoma: a systematic review and meta-analysis
por: Zhang, Ting, et al.
Publicado: (2023)

Proteomics profiling for the global and acetylated proteins of papillary thyroid cancers
por: Wei, Wei, et al.
Publicado: (2023)

The changing incidence of thyroid carcinoma in Shenyang, China before and after universal salt iodization
por: Dong, Wenwu, et al.
Publicado: (2013)

S100A1 is a Potential Biomarker for Papillary Thyroid Carcinoma Diagnosis and Prognosis
por: Wang, Ge, et al.
Publicado: (2021)

Follicular dendritic cell sarcoma presenting as a thyroid mass: an unusual case report and literature review
por: Zhang, Ting, et al.
Publicado: (2020)

Serum biomarkers of papillary thyroid cancer
por: Makki, Fawaz M, et al.
Publicado: (2013)

Herbal Active Ingredients: An Emerging Potential for the Prevention and Treatment of Papillary Thyroid Carcinoma
por: Yang, Yang, et al.
Publicado: (2020)

Insight of novel biomarkers for papillary thyroid carcinoma through multiomics
por: Liu, Wei, et al.
Publicado: (2023)

Integrated analysis of circulating and tissue proteomes reveals that fibronectin 1 is a potential biomarker in papillary thyroid cancer
por: Ye, Guochao, et al.
Publicado: (2023)

Identification of potential biomarkers and drugs for papillary thyroid cancer based on gene expression profile analysis
por: Qu, Ting, et al.
Publicado: (2016)

Down-regulation of DANCR acts as a potential biomarker for papillary thyroid cancer diagnosis
por: Zhang, Ke, et al.
Publicado: (2019)

Analysis of the strategy of LT4 prescribing and TSH monitoring for thyroid carcinoma after lobectomy
por: Wang, Zhihong, et al.
Publicado: (2020)

A potential biomarker hsa-miR-200a-5p distinguishing between benign thyroid tumors with papillary hyperplasia and papillary thyroid carcinoma
por: Wang, Xian, et al.
Publicado: (2018)

MiR-221, a potential prognostic biomarker for recurrence in papillary thyroid cancer
por: Dai, Lei, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fbi0cqbhh4lsod8nsrarinp8mq